The company has already sent the FDA an application for a seasonal flu vaccine, but the agency will probably wait for ...

We recently published a list of 10 Stocks with Potential to Explode in 2025. In this article, we are going to take a look at ...

Ward said it would be good to see data from studies of other variant vaccine boosters to compare to the Moderna combination. Expert advisors "must already be thinking about the population at risk ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird flu vaccine, Bloomberg News reported on Wednesday, citing sources.

Moderna is a biotechnology company primarily engaged in the development and manufacturing of messenger RNA (mRNA) medicines and vaccines. It spearheads innovation using mRNA technology to pursue ...

Financial giants have made a conspicuous bearish move on Moderna. Our analysis of options history for Moderna MRNA revealed 10 unusual trades. Delving into the details, we found 40% of traders ...

Moderna (MRNA) announced that the Medicines ... The approval is based on data from the Phase 3 clinical trial ConquerRSV, a randomized, placebo-controlled, observer-blind, case-driven clinical ...

Moderna recently experienced a notable 10% price increase over the last week amidst significant legal and financial developments. Genevant Sciences and Arbutus Biopharma have expanded their patent ...

Moderna Inc.’s stock tumbled 4% Thursday after a report that health officials are reviewing a contract the company won from the Biden administration to support efforts to develop a bird-flu ...